Gonzalo
Fernández Hinojal
Colaborador Médico
Publicaciones (18) Publicaciones de Gonzalo Fernández Hinojal
2024
-
PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key immunotherapy targets
EMBO Molecular Medicine, Vol. 16, Núm. 8, pp. 1791-1816
2023
-
Plasma fractalkine contributes to systemic myeloid diversity and PD-L1/PD-1 blockade in lung cancer
EMBO Reports, Vol. 24, Núm. 8
-
Prognostic value of human leukocyte antigen G expression in solid tumors: a systematic review and meta-analysis
Frontiers in Immunology, Vol. 14
2022
-
Circulating Low Density Neutrophils Are Associated with Resistance to First Line Anti-PD1/PDL1 Immunotherapy in Non-Small Cell Lung Cancer
Cancers, Vol. 14, Núm. 16
-
Clinical landscape of LAG-3-targeted therapy
Immuno-Oncology and Technology, Vol. 14
-
The multi-specific VH-based Humabody CB213 co-targets PD1 and LAG3 on T cells to promote anti-tumour activity
British Journal of Cancer, Vol. 126, Núm. 8, pp. 1168-1177
-
Transcriptomic Mapping of Non-Small Cell Lung Cancer K-RAS p.G12C Mutated Tumors: Identification of Surfaceome Targets and Immunologic Correlates
Frontiers in Immunology, Vol. 12
2021
-
A proteomic atlas of lineage and cancer-polarized expression modules in myeloid cells modeling immunosuppressive tumor-infiltrating subsets
Journal of Personalized Medicine, Vol. 11, Núm. 6
-
Genomic mapping of splicing-related genes identify amplifications in lsm1, clns1a, and ilf2 in luminal breast cancer
Cancers, Vol. 13, Núm. 16
-
Understanding lag-3 signaling
International Journal of Molecular Sciences, Vol. 22, Núm. 10
2020
-
PD-L1 in systemic immunity: Unraveling its contribution to PD-1/PD-L1 blockade immunotherapy
International Journal of Molecular Sciences, Vol. 21, Núm. 16, pp. 1-17
-
Systemic blood immune cell populations as biomarkers for the outcome of immune checkpoint inhibitor therapies
International Journal of Molecular Sciences, Vol. 21, Núm. 7
2019
-
Functional systemic CD4 immunity is required for clinical responses to PD-L1/PD-1 blockade therapy
EMBO Molecular Medicine, Vol. 11, Núm. 7
-
PD-L1 expression in systemic immune cell populations as a potential predictive biomarker of responses to PD-L1/PD-1 blockade therapy in lung cancer
International Journal of Molecular Sciences, Vol. 20, Núm. 7
2018
-
Characterization of Macrophage Endogenous S-Nitrosoproteome Using a Cysteine-Specific Phosphonate Adaptable Tag in Combination with TiO2 Chromatography
Journal of Proteome Research, Vol. 17, Núm. 3, pp. 1172-1182
-
Myeloid-Derived Suppressor Cells in the Tumor Microenvironment: Current Knowledge and Future Perspectives
Archivum Immunologiae et Therapiae Experimentalis, Vol. 66, Núm. 2, pp. 113-123
2017
-
PD-L1 signal transduction mechanisms in cancer cells
Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry, Vol. 17, Núm. 2, pp. 72-86
-
PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity
Cell Reports, Vol. 20, Núm. 8, pp. 1818-1829